PA
PFE icon

Pineridge Advisors’s Pfizer PFE Stock Holding History

Pineridge Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$16.2K Hold
634
– – ﹤0.01% 176
2025
Q2 		$15.4K Buy
634
+200
+46% +$4.66K 0.01% 183
2025
Q1 		$11K Sell
434
-278
-39% -$7.28K ﹤0.01% 220
2024
Q4 		$18.9K Buy
712
+278
+64% +$7.54K 0.01% 231
2024
Q3 		$12.6K Hold
434
– – ﹤0.01% 260
2024
Q2 		$12.1K Sell
434
-325
-43% -$8.95K ﹤0.01% 260
2024
Q1 		$21.1K Sell
759
-620
-45% -$17.2K 0.01% 220
2023
Q4 		$39.7K Buy
+1,379
New +$41.7K 0.01% 182

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Pineridge Advisors's PFE Position: Q3 2025 in Review

Pineridge Advisors held its Pfizer (PFE) position steady in Q3 2025 at 634 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #176.

Pineridge Advisors first reported a position in PFE in Q4 2023 and has held it in 8 quarters since. The position peaked at $39.7K in Q4 2023. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Pineridge Advisors held 634 shares of Pfizer worth $16.2K as of Q3 2025.
  • Pineridge Advisors left its Pfizer share count unchanged in Q3 2025.
  • Pfizer made up ﹤0.01% of Pineridge Advisors's portfolio in Q3 2025, its #176 holding.
  • Pineridge Advisors first reported a position in Pfizer in Q4 2023 and has held it in 8 quarters since.
  • Pineridge Advisors's Pfizer position peaked at $39.7K in Q4 2023.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.